Komori
Governance2395SHIN NIPPON BIOMEDICAL LABORATORIES,LTD.Information and Communications, Services and Others

Notice Regarding Partial Amendments to the Articles of Incorporation

The person authorized to convene and chair shareholders’ meetings and meetings of the Board of Directors will change from the President and Representative Director to the Chairman of the Board. The order of succession for acting in these roles will also be established: the President will act if the chairman’s position is vacant or the chairman designates the President, and the Vice President will act if both the Chairman and the President are unable to do so.

Worth reading
70In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Contents of this filing

Changes this time

The person authorized to convene and chair shareholders’ meetings and meetings of the Board of Directors will change from the President and Representative Director to the Chairman of the Board. A new provision will establish that the President will act if the chairman’s position is vacant or the chairman designates the President, and that the Vice President will act if both the Chairman and the President are unable to do so.

この書類は、機関設計や取締役会の構成そのものは述べていません。上に示したのは、この書類が述べている変更点です。

Contents of this filing
ItemDetails
Changes this timeThe person authorized to convene and chair shareholders’ meetings and meetings of the Board of Directors will change from the President and Representative Director to the Chairman of the Board. A new provision will establish that the President will act if the chairman’s position is vacant or the chairman designates the President, and that the Vice President will act if both the Chairman and the President are unable to do so.
Items this document does not state (7)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defensesControlling shareholder

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To further strengthen and enhance corporate governance and to contribute to greater flexibility in the Company’s future management structure.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding Partial Amendments to the Articles of Incorporation | SHIN NIPPON BIOMEDICAL LABORATORIES,LTD. (2395) timely disclosure | Komori